TetraLogic Pharmaceuticals Corp (TLOG)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

P.O. BOX 1305 PAOLI, NY 19301

TetraLogic Pharmaceuticals Corporation operates as a biopharmaceutical company. The company discovers and develops small molecule peptide-mimetic drugs for the treatment of cancers. TetraLogic Pharmaceuticals Corporation offers its products throughout the United States.

Data as of 2021-08-02 08:31:37 -0400
Market Cap510.243 Thousand Shares Outstanding24.769 Million Avg 30-day Volume47.513 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low0.06 / 0.0071 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from TLOG instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 1 1 0.0% (0.0%) (0.0%)
13F shares: 3.913 Thousand 3.913 Thousand 0.0%
% Ownership 0.0158 0.016 -1.25%
New Positions: 1
Increased Positions
Closed Positions
Reduced Positions
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TLOG (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TLOG BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ROBINS DAVID C.

3,000,000 2017-09-15 0

STATE OF NEW JERSEY COMMON PENSION FUND D

  • SEE REMARKS
No longer subject to file 2016-11-14 0

HIGHBRIDGE CAPITAL MANAGEMENT LLC

  • SEE REMARKS
No longer subject to file 2016-11-14 0

LAZARD ASSET MANAGEMENT LLC

  • SEE REMARKS
No longer subject to file 2016-11-14 0

LINDEN ADVISORS LP

LINDEN CAPITAL L.P.

  • SEE REMARKSSEE REMARKS
No longer subject to file 2016-11-14 0

TELEMETRY SECURITIES, L.L.C.

  • SEE REMARKS
No longer subject to file 2016-11-14 0

GEODE CAPITAL MANAGEMENT LP

  • SEE REMARKS
No longer subject to file 2016-11-14 0

HUDSON BAY CAPITAL MANAGEMENT LP

GERBER SANDER

  • SEE REMARKSSEE REMARKS
No longer subject to file 2016-11-14 0

NOMURA SECURITIES INTERNATIONAL, INC.

NOMURA HOLDINGS INC

  • SEE REMARKSSEE REMARKS
No longer subject to file 2016-11-14 0

WHITEBOX ADVISORS LLC

WHITEBOX GENERAL PARTNER LLC

WHITEBOX RELATIVE VALUE PARTNERS, L.P.

WHITEBOX MULTI-STRATEGY PARTNERS LP

PANDORA SELECT PARTNERS, L.P.

WHITEBOX GT FUND, LP

  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
No longer subject to file 2016-11-14 0

HUTCHISON PATRICK CFO & TREASURER

  • Officer
7,000 2016-04-30 0

CLARUS LIFESCIENCES II, L.P.

CLARUS VENTURES II GP, L.P.

CLARUS VENTURES II, LLC

GALAKATOS NICHOLAS

HENNER DENNIS

LIPTAK ROBERT

SIMON NICHOLAS

STEINMETZ MICHAEL

WHEELER KURT

  • 10% Owner
No longer subject to file 2016-02-08 0

PECORA ANDREW L

  • Director
184,830 2015-07-10 0

SCHMITT PAUL J

  • Director
1,542,962 2015-07-02 0

MEYERS PETE A. CFO & TREASURER

  • Officer
153,891 2015-03-27 0

BUCHI J KEVIN PRESIDENT & CEO

  • Officer
  • Director
330,714 2015-03-26 0

SHERMAN RICHARD L. SEE REMARKS

  • Officer
0 2015-01-28 0

BEGLEY COLIN GLENN CHIEF SCIENTIFIC OFFICER & SVP

  • Officer
0 2015-01-28 0

REED DOUGLAS MD

  • Director
0 2015-01-28 0

WOODY JAMES N.

  • Director
0 2015-01-28 0

RUSSELL LESLEY CHIEF OPERATING OFFICER

  • Officer
0 2015-01-28 0

GRAY MARY ANN

  • Director
0 2015-01-28 0

KISHBAUCH MICHAEL D

  • Director
0 2015-01-28 0

ONSI DOUGLAS E

  • Director
0 2015-01-28 0

STEINMETZ MICHAEL

  • Director
0 2015-01-28 0

GAVIN BRENDA D

  • Director
948,268 2013-12-17 0

HEALTHCARE VENTURES VII LP

HEALTHCARE PARTNERS VII, L.P.

LAWLOR AUGUSTINE

LITTLECHILD JOHN W

MIRABELLI CHRISTOPHER

ONSI DOUGLAS E

WERNER HAROLD R

CAVANAUGH JAMES H

  • Director
  • 10% Owner
2,586,466 2013-12-17 0

AMGEN INC

AMGEN VENTURES LLC

  • 10% Owner
No longer subject to file 2013-12-17 0

GILL JOHN

  • Director
40,312 2013-12-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 22:15:03 UTC -8.0031 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 21:45:03 UTC -8.0031 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 21:15:03 UTC -8.0031 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 20:45:03 UTC -8.0031 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 20:15:03 UTC -8.0031 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 19:45:03 UTC -8.0031 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 19:15:03 UTC -8.0031 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 18:45:03 UTC -8.0031 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 18:15:03 UTC -8.0031 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 17:45:03 UTC -8.0031 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 17:15:03 UTC -8.0031 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 16:45:03 UTC -7.9831 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 16:15:03 UTC -7.9831 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 15:45:03 UTC -7.9831 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 15:15:03 UTC -7.9831 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 14:45:03 UTC -7.9831 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 14:15:03 UTC -7.9831 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 13:45:03 UTC -7.9831 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 13:15:04 UTC -7.9831 8.0631 250000
TETRALOGIC PHARMACEUTICALS C TLOG 2021-08-02 12:45:03 UTC -7.9831 8.0631 250000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments